Results 151 to 160 of about 859,972 (336)

The optimal treatment of multivessel coronary artery disease [PDF]

open access: yes, 2014
The practice of percutaneous coronary intervention has overtaken coronary bypass surgery in the treatment of ischaemic heart disease. Several randomized controlled as well as registry and observational trials have addressed the issue of patient selection
Manche, Alexander
core  

Incidence and 1‐Year Prognostic of Unstable Angina After High‐Sensitivity Troponin Assessment

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 6, Page 1445-1452, May 1, 2025.
ABSTRACT Background Incidence and prognostic of unstable angina after high‐sensitivity troponin assesment is controversial. Aims This study evaluated prognostic of a contemporary population of patients with UA defined using high sensitive T troponin (T hs‐cTn) measurements and with significant coronary artery disease (CAD). Methods Consecutive patients
Romain Jouen   +10 more
wiley   +1 more source

Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models

open access: yesBMC Cardiovascular Disorders, 2005
BackgroundMycophenolate mofetil (MMF), the prodrug of mycophenolic acid (MPA), is a rationally designed immunosuppressive drug. The current study investigates the effect of MMF on key pattern of restenosis in a cascade of in vitro and ex vivo models ...
R. Voisard   +7 more
semanticscholar   +1 more source

Coronary CT Angiography- Based Assessment of Coronary in-Stent Restenosis: A Journey through Past and Present Trends

open access: yesJournal of the Korean Society of Radiology
Treatment of patients with coronary artery disease commonly involves the use of balloon-expandable stent placements, currently recognized as the most prevalent approach for coronary artery revascularization.
Yoon Seong Lee, Eun-Ah Park, Whal Lee
doaj   +1 more source

30‐Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable‐Polymer Sirolimus‐Eluting Ultra‐Thin Stent

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 6, Page 1502-1509, May 1, 2025.
ABSTRACT Background There is limited evidence on the safety and efficacy of biodegradable‐polymer sirolimus‐eluting ultra‐thin stent (BP‐SES) in patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). Aims This study aims to evaluate the clinical outcomes of HBR patients treated with BP‐SES and ≤ 30‐day dual ...
Andrea Erriquez   +9 more
wiley   +1 more source

Patient-specific coronary angioplasty simulations -- a mixed-dimensional finite element modeling approach [PDF]

open access: yesarXiv
Coronary angioplasty with stent implantation is the most frequently used interventional treatment for coronary artery disease. However, reocclusion within the stent, referred to as in-stent restenosis, occurs in up to 10% of lesions. It is widely accepted that mechanical loads on the vessel wall strongly affect adaptive and maladaptive mechanisms. Yet,
arxiv  

Simulating Drug-Eluting Stents: Progress Made and the Way Forward [PDF]

open access: yes, 2013
Drug-eluting stents have significantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary ...
Kennedy, Simon   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy